Clinical Trials Logo

Clinical Trial Summary

Febrile seizure (FS) is a common neurological condition in children, affecting 2 - 14% of children. FS is defined as seizures occurring in a child aged from six months to five years that is accompanied by a fever (≥38°C) without central nervous system infection. FS is classified into simple febrile seizure (SFS) and complex febrile seizure (CFS). SFS accounts for 70-75% of FS cases and is characterized by being generalized, duration of less than 15 minutes, occurs once in 24 hours, and no previous neurologic problems. We aim to investigate serum levels of adipocytokines, specifically leptin, adiponectin, and IL-6, in children with FS.


Clinical Trial Description

The study will include three groups of children (100 for each): children with febrile seizures (group 1), febrile children without seizures (group 2), and healthy control children (group 3). Children included in this study will undergo: - Thorough medical history taking: including age, gender, and seizure details for children with febrile seizures (e.g., type, duration, recurrence). - Physical examination: including vital signs (particularly temperature) and comprehensive neurological examination). - Laboratory investigations: - Routine investigations: complete blood count, C-reactive protein, blood glucose, serum electrolytes (sodium, potassium, calcium, and magnesium), liver and kidney function tests. - Serum leptin and adiponectin: venous blood samples (3 ml) will be obtained from children with FS (within 3 hours of seizures) as well as the two control groups. Serum will be obtained by centrifugation at 3,500 rpm for 5 min at 4 ℃. The serum will be immediately separated and stored at -70 ℃. Serum leptin and adiponectin will be assessed through enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's instructions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04967066
Study type Observational [Patient Registry]
Source Sohag University
Contact
Status Completed
Phase
Start date August 23, 2021
Completion date October 2, 2022

See also
  Status Clinical Trial Phase
Completed NCT03481764 - Anthropogenetic Variability in the Group of Individuals With Febrile Seizures
Not yet recruiting NCT05008458 - Value of Von Willebrand Factor and Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital
Completed NCT04368936 - Relationship Between Polymorphisms of TRPV1 and KCC2 Gene in Children With Febrile Seizures
Completed NCT01694524 - Nervous System Infections Among Patients With Febrile Seizure N/A
Not yet recruiting NCT05947006 - Study of the Impact of a Pediatric Nurse's Consultation on Parental Anxiety During a Febrile Convulsion in Children N/A
Recruiting NCT05215366 - Value of Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital
Completed NCT03165981 - Fever After Simultaneous Versus Sequential Vaccination in Young Children Phase 4
Terminated NCT01370044 - Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures Phase 2/Phase 3